DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+16.06%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$126M
AUM Growth
+$126M
(+27%)
Cap. Flow
+$12.5M
Cap. Flow
% of AUM
9.87%
Top 10 Holdings %
Top 10 Hldgs %
54.03%
Holding
70
New
10
Increased
16
Reduced
10
Closed
8
Top Buys
| 1 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$3.36M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$3.1M |
| 3 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$2.1M |
| 4 |
Rigel Pharmaceuticals
RIGL
|
$1.7M |
| 5 |
TRVN
Trevena, Inc.
TRVN
|
$1.67M |
Top Sells
| 1 |
XNPT
XENOPORT, INC.
XNPT
|
$1.25M |
| 2 |
BLUE
bluebird bio
BLUE
|
$1.15M |
| 3 |
Neurocrine Biosciences
NBIX
|
$1.04M |
| 4 |
BSTC
BioSpecifics Technologies Corp.
BSTC
|
$1.03M |
| 5 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$846K |
Sector Composition
| 1 | Healthcare | 59.53% |
| 2 | Financials | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Protara Therapeutics
TARA
$120M
| $132K | 0.1% | +12,700 | New | +$132K |
|
|
CEMI
52
DELISTED
Chembio diagnostics, Inc.
CEMI
| $103K | 0.08% | 26,287 -28,915 | -52% | -$113K |
|
|
GBIM
53
DELISTED
GLOBEIMMUNE INC COM STK (DE)
GBIM
| $83K | 0.07% | 10,945 +200 | +2% | +$1.52K |
|
54
InspireMD
NSPR
$102M
| $50K | 0.04% | 63,700 | – | – |
|
55
Curis
CRIS
$20.9M
| – | – | -150,000 | Closed | -$212K |
|
|
56
Neurocrine Biosciences
NBIX
$13.8B
| – | – | -66,141 | Closed | -$1.04M |
|
57
Retractable Technologies
RVP
$25.1M
| – | – | -20,000 | Closed | -$58K |
|
58
SCYNEXIS
SCYX
$34.9M
| – | – | -50,000 | Closed | -$370K |
|
59
Tonix Pharmaceuticals
TNXP
$260M
| – | – | -25,000 | Closed | -$171K |
|
60
Vericel Corp
VCEL
$1.83B
| – | – | -238,900 | Closed | -$681K |
|
|
AMPE
61
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| – | – | -150,000 | Closed | -$530K |
|
|
CASC
62
DELISTED
Cascadian Therapeutics, Inc.
CASC
| – | – | -214,972 | Closed | -$413K |
|